Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma

Name: Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
License: Public Domain

David Bond, MD

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

aggressive non-hodgkin lymphoma, ann arbor stage i primary mediastinal (thymic) large b-cell cell lymphoma, ann arbor stage ii b-cell non-hodgkin lymphoma, ann arbor stage ii primary mediastinal (thymic) large b-cell cell lymphoma, ann arbor stage iii b-cell non-hodgkin lymphoma, ann arbor stage iii primary mediastinal (thymic) large b-cell cell lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 429761
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.